Board Meetings for GLENMARK
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| GLENMARK | Glenmark Pharmaceuticals Limited | 14 Feb 2019 | Financial Results | To consider and approve the financial results for the period ended December 31, 2018 | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 13 Nov 2018 | Financial Results | to consider and approve the Unaudited Financial Results of the Company for the Second Quarter and Half Year ended September 30, 2018 | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 28 Sept 2018 | Other business matters | Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to consider repurchase of Foreign Currency Debt | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 10 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 29 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 08 Feb 2018 | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2017. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 02 Nov 2017 | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the Second Quarter and Half year ended September 30, 2017. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 27 Jul 2017 | Results | to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2017. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 11 May 2017 | Results/Dividend | to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the year ended March 31, 2017 and to consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2017. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 02 Feb 2017 | Results | to consider and approve the Company s Unaudited Financial Statements for the Third Quarter and Nine months ended December 31, 2016. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 27 Oct 2016 | Results | to consider and approve the Company s Unaudited Financial Statements for the Second Quarter/Half Year ended September 30, 2016. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 12 Aug 2016 | Results | To consider and approve the Company s Unaudited Financial Statements for the First Quarter ended June 30, 2016. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 12 May 2016 | Results/Dividend | 1. To consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2016.2. To Consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2016. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 28 Jan 2016 | Results | to consider and approve the Company's Unaudited Financial Statements for the Third Quarter ended December 31, 2015. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 29 Oct 2015 | Results | to consider and approve the Company's Unaudited Financial Statements for the Second Quarter/Half Year ended September 30, 2015. |